ConductScience.org, home

Paper236108

Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo.

Sunshine A. Clin Pharmacol Ther, 1975. Cited by 31 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo. Papers, record 236108. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/236108

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
2.31
iCite
Revised in PubMed
2019-05-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sunshine AA

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
BenzazepinesMajor topic
FlurazepamMajor topic
Hypnotics and SedativesMajor topic
Sleep Initiation and Maintenance DisordersMajor topic
Adult
Aged
Chlorobenzenes
Clinical Trials as Topic
Dose-Response Relationship, Drug
Female
Humans
Male
Middle Aged
Placebos
Triazoles

Source PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
31,496,087The assessment and management of insomnia: an update.World Psychiatry2019https://conductscience.org/library/papers/31496087PubMed
27,998,379Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.J Clin Sleep Med2017https://conductscience.org/library/papers/27998379PubMed
10,674,059Meta-analysis of benzodiazepine use in the treatment of insomnia.CMAJ2000https://conductscience.org/library/papers/10674059PubMed
6,133,533Approaches in the evaluation of hypnotics: studies with triazolam.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6133533PubMed
6,118,170Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6118170PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/236108

GET https://conductscience.org/api/papers/v1/236108/authors